Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
1.650
-0.070 (-4.07%)
Aug 20, 2026, 2:44 PM EDT - Market open
Curis Revenue
Curis had revenue of $4.31M in the twelve months ending June 30, 2026, down -62.17% year-over-year. In the year 2025, Curis had annual revenue of $9.44M, down -13.43%.
Revenue (ttm)
$4.31M
Revenue Growth
-62.17%
P/S Ratio
0.78
Revenue / Employee
$179,750
Employees
24
Market Cap
3.22M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.44M | -1.47M | -13.43% |
| Dec 31, 2024 | 10.91M | 885.00K | 8.83% |
| Dec 31, 2023 | 10.02M | -139.00K | -1.37% |
| Dec 31, 2022 | 10.16M | -487.00K | -4.57% |
| Dec 31, 2021 | 10.65M | -186.00K | -1.72% |
| Dec 31, 2020 | 10.84M | 831.00K | 8.31% |
| Dec 31, 2019 | 10.00M | -424.00K | -4.07% |
| Dec 31, 2018 | 10.43M | 530.00K | 5.35% |
| Dec 31, 2017 | 9.90M | 2.37M | 31.50% |
| Dec 31, 2016 | 7.53M | -351.00K | -4.46% |
| Dec 31, 2015 | 7.88M | -1.97M | -19.96% |
| Dec 31, 2014 | 9.84M | -5.16M | -34.39% |
| Dec 31, 2013 | 15.00M | -1.97M | -11.61% |
| Dec 31, 2012 | 16.97M | 2.21M | 14.97% |
| Dec 31, 2011 | 14.76M | -1.24M | -7.73% |
| Dec 31, 2010 | 16.00M | 7.41M | 86.26% |
| Dec 31, 2009 | 8.59M | 223.32K | 2.67% |
| Dec 31, 2008 | 8.37M | -8.02M | -48.95% |
| Dec 31, 2007 | 16.39M | 1.45M | 9.73% |
| Dec 31, 2006 | 14.94M | 8.93M | 148.83% |
| Dec 31, 2005 | 6.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
CRIS News
- 3 days ago - Curis announces pricing of $5.6M public offering - TheFly
- 5 days ago - Curis Quarterly report: Q2 2026 - Filings
- 7 days ago - Curis, Inc. Announces Pricing of $5.6 Million Public Offering - PRNewsWire
- 9 days ago - Curis files to sell 3.73M shares of common stock, warrants - TheFly
- 10 days ago - Curis Registration statement: Registration filing - Filings
- 21 days ago - Curis doses first five patients in TakeAim CLL study - TheFly
- 21 days ago - Curis Doses First Five Patients in TakeAim CLL Study - PRNewsWire
- 27 days ago - Curis price target raised to $43 from $17 at H.C. Wainwright - TheFly